These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8537387)

  • 21. Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells.
    Weng Z; Taylor JA; Turner CE; Brugge JS; Seidel-Dugan C
    J Biol Chem; 1993 Jul; 268(20):14956-63. PubMed ID: 8325872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Csk enhances insulin-stimulated dephosphorylation of focal adhesion proteins.
    Tobe K; Sabe H; Yamamoto T; Yamauchi T; Asai S; Kaburagi Y; Tamemoto H; Ueki K; Kimura H; Akanuma Y; Yazaki Y; Hanafusa H; Kadowaki T
    Mol Cell Biol; 1996 Sep; 16(9):4765-72. PubMed ID: 8756634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. v-Crk-induced cell transformation: changes in focal adhesion composition and signaling.
    Nievers MG; Birge RB; Greulich H; Verkleij AJ; Hanafusa H; van Bergen en Henegouwen PM
    J Cell Sci; 1997 Feb; 110 ( Pt 3)():389-99. PubMed ID: 9057091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for Ras in v-Crk transformation.
    Greulich H; Hanafusa H
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.
    Fajardo JE; Birge RB; Hanafusa H
    Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
    Jong SM; Zong CS; Dorai T; Wang LH
    J Virol; 1992 Aug; 66(8):4909-18. PubMed ID: 1321277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the kinase activity essential for tyrosine phosphorylation of p130Cas in fibroblasts.
    Sakai R; Nakamoto T; Ozawa K; Aizawa S; Hirai H
    Oncogene; 1997 Mar; 14(12):1419-26. PubMed ID: 9136985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.
    Mayer BJ; Hanafusa H
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2638-42. PubMed ID: 1690891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
    Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling.
    Kirsch K; Kensinger M; Hanafusa H; August A
    BMC Cell Biol; 2002 Jul; 3():18. PubMed ID: 12119061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein.
    Lamorte L; Kamikura DM; Park M
    Oncogene; 2000 Dec; 19(52):5973-81. PubMed ID: 11146548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases.
    Kanner SB; Reynolds AB; Vines RR; Parsons JT
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3328-32. PubMed ID: 2110361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading.
    Bergman M; Joukov V; Virtanen I; Alitalo K
    Mol Cell Biol; 1995 Feb; 15(2):711-22. PubMed ID: 7529872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. v-src-induced cell shape changes in rat fibroblasts require new gene transcription and precede loss of focal adhesions.
    Meijne AM; Ruuls-Van Stalle L; Feltkamp CA; McCarthy JB; Roos E
    Exp Cell Res; 1997 Aug; 234(2):477-85. PubMed ID: 9260918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
    Salgia R; Li JL; Lo SH; Brunkhorst B; Kansas GS; Sobhany ES; Sun Y; Pisick E; Hallek M; Ernst T
    J Biol Chem; 1995 Mar; 270(10):5039-47. PubMed ID: 7534286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.
    Neet K; Hunter T
    Mol Cell Biol; 1995 Sep; 15(9):4908-20. PubMed ID: 7544435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paxillin interactions.
    Turner CE
    J Cell Sci; 2000 Dec; 113 Pt 23():4139-40. PubMed ID: 11069756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo.
    Missbach M; Jeschke M; Feyen J; Müller K; Glatt M; Green J; Susa M
    Bone; 1999 May; 24(5):437-49. PubMed ID: 10321903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.